Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chinook Therapeutics (KDNY)
NASDAQ:KDNY
Holding KDNY?
Track your performance easily
KDNY Stock Chart & Stats
Day’s Range$40.3 - $40.51
52-Week Range― - ―
Previous Close$40.3
Volume4.92M
Average Volume (3M)N/A
Market Cap
$2.90B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$40.36Price Target Upside-0.07% Downside
Rating ConsensusHold
Number of Analyst Covering12
Chinook Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
KDNY FAQ
What was Chinook Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Chinook Therapeutics’s market cap?
Currently, no data Available
When is Chinook Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Chinook Therapeutics’s earnings last quarter?
Currently, no data Available
Is Chinook Therapeutics overvalued?
According to Wall Street analysts Chinook Therapeutics’s price is currently Overvalued.
Does Chinook Therapeutics pay dividends?
Chinook Therapeutics does not currently pay dividends.
What is Chinook Therapeutics’s EPS estimate?
Chinook Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chinook Therapeutics have?
Currently, no data Available
What happened to Chinook Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chinook Therapeutics?
Among the largest hedge funds holding Chinook Therapeutics’s share is Baker Bros Advisors LP. It holds Chinook Therapeutics’s shares valued at 34M.
---
Chinook Therapeutics Stock Smart Score
Company Description
Chinook Therapeutics
Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.
---
KDNY Stock 12 Month Forecast
Average Price Target
$40.36
▼(-0.07% Downside)
Best Analysts Covering KDNY
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+11.58%
reiterated a buy rating 2 years ago
Copying Justin Kim's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.58% per trade.
---